Project CAIN457ADE15 Pinpoint

Basic data

Title:
CAIN457ADE15 Pinpoint
Duration:
30/10/2020 to 31/12/2022
Abstract / short description:
A randomized, double-blind, multicenter, 24-week study of subcutaneous secukinumab to assess anti-interleukin-17A treatment in plaque psoriasis patients with coexisting non-alcoholic fatty liver disease (pINPOINt)
EUDRACT number: 2019-003168-37
Keywords:
psoriasis therapeutics
Psoriasis Therapeutika
psoriasis
Schuppenflechte

Involved staff

Managers

Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Faculty of Medicine
University of Tübingen

Local organizational units

Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine

Funders

Nürnberg, Bayern, Germany
Help

will be deleted permanently. This cannot be undone.